Can lamotrigine be used in patients with substance use disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lamotrigine in Patients with Substance Use Disorders

Lamotrigine can be safely and effectively used in patients with substance use disorders, with evidence specifically supporting its use in those with alcohol and cocaine dependence.

Evidence for Lamotrigine in Substance Use Disorders

Alcohol Dependence

  • In a 12-week open-label study of 28 patients with bipolar disorder and alcohol dependence, lamotrigine was associated with:
    • Significant improvement in mood symptoms
    • Decreased alcohol craving
    • Reduced alcohol consumption (measured by carbohydrate-deficient transferrin levels)
    • Good tolerability with no dropouts due to adverse events 1

Cocaine Dependence

  • A similar 12-week study of 30 patients with bipolar disorder and cocaine dependence found:
    • Significant improvement in depression, mania, and psychiatric symptoms
    • Significant reduction in cocaine cravings
    • Good tolerability with no discontinuations due to side effects 2

Clinical Considerations for Prescribing

Dosing and Titration

  • Start at low doses (25 mg/day) and titrate slowly to minimize risk of serious rash
  • Standard titration involves a 6-week period to reach target dose of 200 mg/day 3
  • Dose adjustments required when co-administered with other medications:
    • Lower starting dose (12.5 mg/day) when used with valproate 2
    • Dose adjustments needed with enzyme-inducing antiepileptic drugs 4

Special Considerations for Substance Use Disorder Patients

  • For patients with opioid use disorder:
    • Collaboration with substance use disorder specialists is strongly recommended when managing pain in these patients 5
    • No significant interactions reported between lamotrigine and methadone or buprenorphine
    • Unlike benzodiazepines, lamotrigine does not have abuse potential

Monitoring and Safety

  • Monitor for development of rash, particularly during initial titration period
  • Risk of serious rash (including Stevens-Johnson syndrome) is approximately 0.1% in bipolar patients 3
  • Risk factors for serious rash include:
    • Rapid dose escalation
    • Concurrent valproate use
    • Pediatric patients 4

Advantages of Lamotrigine in Substance Use Disorder Population

  • Does not require serum level monitoring unlike lithium 3
  • Does not cause weight gain, which improves adherence 3
  • Low potential for causing sedation or cognitive impairment
  • No evidence of abuse potential or withdrawal syndrome
  • Can be used as monotherapy or as part of a comprehensive treatment approach

Potential Concerns

  • Rare psychiatric side effects have been reported, including:
    • Affective switches
    • Psychotic episodes
    • Hallucinations 6
  • These side effects should be monitored, especially in patients with comorbid psychiatric and substance use disorders

In conclusion, lamotrigine represents a valuable treatment option for patients with substance use disorders, particularly those with comorbid bipolar disorder. Its favorable side effect profile, lack of abuse potential, and evidence for reducing cravings make it particularly suitable for this population.

Related Questions

In bipolar I disorder, is Lamictal (lamotrigine) 400 mg appropriate when no enzyme‑inducing medication is being taken?
What should I do if I experience blanking out episodes while taking lamotrigine and fluvoxamine?
What medication adjustments are recommended for a patient with bipolar disorder, currently experiencing severe depressive and psychotic features, who is already taking Lamictal (lamotrigine) 200 mg and trazodone 200 mg for insomnia, and has been administered a vaccine (unknown type) 150 mg?
What can be done for a patient on lamotrigine (Lamictal) and duloxetine (Cymbalta) who is experiencing worsening night sweats and hot flashes after starting lamotrigine?
Can Lamictal (lamotrigine) be used in the management of Unspecified Mood (Affective) Disorder, F90.9?
What adjustments should be made to the patient's NP thyroid (Natural Porcine Thyroid) dosage given elevated Thyroid-Stimulating Hormone (TSH) levels, normal Free Thyroxine (Free T4) levels, elevated Reverse Triiodothyronine (Reverse T3) levels, and normal Free Triiodothyronine (Free T3) levels?
What is the recommended prophylaxis dose of fluconazole (antifungal medication) in immunocompromised patients?
What is the recommended dosing for estriol vaginal cream (estriol) for the treatment of vaginal atrophy?
What is the recommended dose of Augmentin (amoxicillin/clavulanate) for a renal transplant patient with impaired renal function, specifically a Glomerular Filtration Rate (GFR) of 50?
What are the expected urine toxicology (utox) results for individuals taking Adderall (amphetamine and dextroamphetamine) as prescribed?
What patient education is recommended for someone exposed to meningitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.